DRC Receives 70,000 Ebola Vaccine Doses Amid Outbreak

The Democratic Republic of Congo has received 70,000 doses of the Ebola vaccine from the global stockpile managed by the International Coordinating Group (ICG) on Vaccine Provision following an emergency request made last week. The World Health Organization (WHO) stated that 20,000 of these doses will be utilized in a late-stage clinical trial to determine if the vaccine Ervebo can protect against the Bundibugyo species of the Ebola virus, which is currently responsible for an outbreak in the country.

The Bundibugyo virus lacks an approved vaccine or treatment, and it remains uncertain whether Ervebo, which is approved for the Zaire ebolavirus, can provide protection against this strain. The clinical trial is expected to yield significant evidence regarding the vaccine's effectiveness.

As of now, confirmed Ebola cases in Congo have surpassed 5,000, with 2,378 deaths recorded. The ongoing outbreak, which began in late July, has become the largest on record in the country.

WHO Director-General Tedros Adhanom Ghebreyesus has declared the outbreak a global emergency.